Informational only. Not medical advice.INFORMATIONAL PLATFORM ONLY — NOT MEDICAL ADVICE, DIAGNOSIS, OR TREATMENT
Informational only. Not medical advice.INFORMATIONAL PLATFORM ONLY — NOT MEDICAL ADVICE, DIAGNOSIS, OR TREATMENT
FDA warning letters, DEA scheduling changes, state board actions, and legislative updates — all in one feed. The peptide and compounding industry moves fast. Stay ahead of enforcement.
Every warning letter to compounding pharmacies, peptide vendors, and supplement companies. Parsed for enforcement patterns.
Scheduling proposals, final rules, and classification changes for peptides and related compounds.
State pharmacy board decisions, compounding facility requirements, and prescribing restrictions across all 50 states.
Federal and state bills affecting compounding access, peptide regulation, and pharmacy practice.
Browse the feed for free. Upgrade for email alerts and API access.
No alerts yet. The regulatory feed updates automatically as new FDA, DEA, and state board actions are published.
$199/mo
The FDA is reopening legal compounding for select peptides under its Category 1 bulk drug substances list. Get notified the moment they become available from verified pharmacies.
View the Category 1 listFDA Compliance Scanner
Scan your website for FDA-flagged language before they do.
Regulatory information is provided for informational purposes only and does not constitute legal advice. Consult qualified legal counsel for compliance decisions.
Disclosed Labs